| |
| |
|
| Insider
Information: |
Fernandes Prabhavathi |
| Relationship: |
Director |
| City: |
Chapel Hill |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
250,678 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$28,084 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
250,678 |
|
|
| Total
Value |
$28,084 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Melinta Therapeutics, Inc |
MLNT |
President and CEO, Dir... |
2015-05-22 |
247,678 |
|
0 |
Premium* |
|
|
Ocugen Ord Shs |
OCGN |
Director |
2021-05-25 |
0 |
2021-05-25 |
0 |
Premium* |
|
|
Opgen Inc |
OPGN |
Director |
2023-06-07 |
3,000 |
2021-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPGN |
Opgen Inc |
Director |
– • – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
3,000 |
0 |
- |
|
| OPGN |
Opgen Inc |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
30,000 |
0 |
- |
|
| OPGN |
Opgen Inc |
Director |
– • – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2021-05-25 |
4 |
S |
$8.19 |
$274,755 |
D/D |
(33,500) |
0 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2021-05-25 |
4 |
OE |
$0.28 |
$31,080 |
D/D |
33,500 |
14,000 |
0 |
- |
|
| MLNT |
Melinta Therapeutics, Inc |
President and CEO |
• • – |
2015-05-22 |
4 |
S |
$35.72 |
$321,489 |
D/D |
(9,000) |
247,678 |
0 |
- |
|
| MLNT |
Melinta Therapeutics, Inc |
President and CEO |
• • – |
2015-05-22 |
4 |
OE |
$2.09 |
$318,792 |
D/D |
37,389 |
256,678 |
0 |
- |
|
| MLNT |
Melinta Therapeutics, Inc |
President and CEO |
• • – |
2014-05-14 |
4 |
OE |
$1.43 |
$17,310 |
D/D |
12,105 |
219,289 |
0 |
- |
|
| MLNT |
Melinta Therapeutics, Inc |
President and CEO |
• • – |
2013-05-09 |
4 |
B |
$8.60 |
$30,100 |
D/D |
3,500 |
207,184 |
2.81 |
- |
|
| MLNT |
Melinta Therapeutics, Inc |
President and CEOOfficer |
• • – |
2012-02-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
203,684 |
|
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
